Hepatitis B
Hepatitis B virus
hepatitis b

Hepatitis B is a serious disease caused by a virus that attacks the liver. The virus, which is called hepatitis B virus (HBV), can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death

CNO PDF 16 Aug 02
IMPLEMENTATION OF HEPATITIS B IMMUNIZATION FOR NEW ACCESSIONS
ALARACT PDF 04 Oct 94
HEPATITIS B VACCINATION
ALARACT PDF 05 Dec 91
REVISED HEPATITIS B VIRUS (HBV) IMMUNIZATION PROGRAM FOR THE AMEDD AND FOR SOLDIERS POSING IN KOREA
14 Nov 05

Sample Q&A: The Vaccine

How safe and effective is the vaccine?
Hepatitis B vaccine has an outstanding record of safety and effectiveness. Studies have shown that the vaccine is 95% effective in preventing children and adults from developing chronic infection.
Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP), Part II: Immunization of Adults
Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of Infants, Children, and Adolescents
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MSMR August 2012: Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces,1991-2011
New NDC for GSK Hepatitis B Vaccine (Recombinant) in Prefilled Tip-Lok® Syringe
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP), Part II: Immunization of Adults
Recommendations of the Defense Health Board (DHB)
Recommendations of the Armed Forces Epidemiological Board (AFEB)
MSMR August 2012: Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces,1991-2011
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Comvax (Merck) 01 Dec 10
Package Insert - Vaccine
Hepatitis B Recommendations for Adults
New NDC for GSK Hepatitis B Vaccine (Recombinant) in Prefilled Tip-Lok® Syringe
VIS
Vaccine Information Statement (Interim)
Vaccine Information Statement
Author(s): Wistrom J, Ahlm C, Lundberg S, Settergren B, Tarnvik A
Publication: Vaccine 17 (1999) 2162-2165
Subject: Vaccine-Effectiveness
Disease: Hepatitis B
Author(s): Hadler S, de Monzon MA, Lugo DR, Perez M
Publication: Vaccine, vol. 7
Subject: Vaccine-Safety
Disease: Hepatitis B
Author(s): Marsano LS, West DJ, Chant I, Hesley TM, Cox J, Hackworth V, Greenberg RN
Publication: Vaccine. Vol. 16. No. 6, pp. 624-629
Subject: Vaccine-Effectiveness
Disease: Hepatitis B
Author(s): Jilg W, Schmidt M, Deinhardt F
Publication: Journal d Medical Virology 17:249-254
Subject: Vaccine-Effectiveness
Disease: Hepatitis B